全球止血剂和组织密封胶市场

预计到2030年，美国止血剂和组织密封胶的全球市场规模将达到138亿美元。

2024年全球止血剂和组织密封胶市场规模估计为89亿美元，预计到2030年将达到138亿美元，2024年至2030年的复合年增长率（CAGR）为7.6%。本报告分析的细分市场之一－外科修復应用，预计复合年增长率为7.4%，到分析期结束时将达到52亿美元。重组外科应用细分市场预计在分析期间将以7.5%的复合年增长率成长。

美国市场规模估计为23亿美元，中国市场预计将以11.2%的复合年增长率成长。

预计到2024年，美国止血剂和组织密封胶市场规模将达23亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到34亿美元，在2024年至2030年的分析期间内，复合年增长率（CAGR）将达到11.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期内，这两个市场的复合年增长率将分别达到3.9%和6.8%。在欧洲，德国的复合年增长率预计将达到4.5%。

全球止血剂和组织密封胶市场—主要趋势和驱动因素概述

止血剂和组织密封胶是手术成功背后的无名英雄吗？

止血钳和组织密封胶是现代外科手术中不可或缺的工具，但它们为何对手术成功至关重要？止血钳是用于在手术过程中中止血液的医疗器械，而组织密封剂则用于封闭伤口、加固缝合线并确保最佳癒合。它们共同发挥着至关重要的作用，能够防止过度出血、缩短手术时间并促进伤口缝合。止血是任何手术最基本的目标之一，因为无法控制的出血会导致感染疾病、休克甚至死亡等严重併发症。

止血剂的作用机转包括物理压迫血管、活化人体自身的凝血机製或使用化学製剂止血。而组织密封胶则如同胶水一般，形成屏障，促进伤口缝合与癒合。在心血管整形外科、一般外科和整形外科等多个外科领域，这些工具能够帮助外科医生控制出血、减少输血需求，并促进伤口快速有效癒合。先进止血剂和密封剂的研发彻底革新了外科治疗，为外科医师提供了更精准、更可靠、创伤更小的止血和组织修復方案。

科技如何改变了止血剂和组织密封胶？

技术进步显着提高了止血剂和组织密封胶的有效性、安全性和多功能性，使其成为现代外科手术中不可或缺的工具。其中一项重大创新是开发了这些产品所含的生物活性成分。传统上，外科医生依靠机械压迫或热凝止血。如今，包括胶原蛋白、凝血酶和纤维蛋白在内的生物活性止血剂，透过增强人体自身的凝血过程发挥作用。这些生物活性成分在复杂或微创手术中特别有用，因为在这些手术中，传统技术无法实现或效果不佳。

组织密封胶也取得了显着进展，新的配方提高了其黏合性能和生物相容性。合成密封剂，例如氰基丙烯酸酯类黏合剂，具有很强的黏合性，可用于加固缝线或无需缝合即可闭合切口。由聚乙二醇 (PEG) 等材料製成的可生物降解密封剂，旨在完成预期用途后在体内自然分解，从而降低异物反应和感染疾病的风险。这些进展使得组织密封胶更安全有效，可应用于从器官移植等精细手术到美容手术中常规伤口缝合等各种领域。

另一项重要进展是将止血和组织密封功能整合于单一解决方案中的复合产品的开发。此类多功能产品可同时止血和密封组织，减少多次介入的需要，简化手术流程。此外，微创手术的进步催生了对可透过腹腔镜和机器人手术器械使用的止血剂和密封剂的需求，使外科医生能够在难以触及的区域控制出血并精确密封组织。这些技术进步不仅提高了止血剂和密封剂的性能，也拓展了其在各个医学领域的应用，使手术更加安全和高效。

为什么止血剂和组织密封胶对外科手术结果至关重要？

止血剂和组织密封胶对于手术的成功至关重要，因为它们有助于控制无法控制的出血，而出血是手术中最危险的环节之一。在许多手术中，尤其是在涉及脆弱组织和血管的手术中，即使是少量出血也可能导致严重的併发症。止血剂使外科医生能够立即控制出血，减少需要更具侵入性操作的手术，并确保手术顺利进行。这种控制在急诊手术和创伤救治中尤其重要，因为在这些情况下，必须立即控制快速出血以防止危及生命的情况发生。

除了止血之外，组织密封胶在伤口管理和术后恢復中也发挥着重要作用。透过在手术切口和受损组织周围形成水密密封，这些密封剂可以降低感染疾病风险并促进伤口更快癒合。它们在传统缝合或缝合钉不足以或不适用的手术中特别有用，例如肝切除术、心血管手术和肺部修復。组织密封胶还能加强涉及大面积或高张力伤口的手术，有助于防止伤口撕脱（手术切口再次裂开）和其他术后併发症。

此外，止血剂和组织密封剂的使用可以减少输血的需求，从而降低感染疾病、免疫反应和延长住院时间等风险。这些产品透过最大限度地减少出血和改善伤口缝合，有助于缩短手术时间、加快康復速度并改善患者预后。对于外科医生而言，可靠的止血剂和组织密封剂能够提高手术精度，使他们能够专注于手术的复杂环节，而无需担心出血过多或组织闭合问题。总而言之，策略性地使用止血剂和组织密封胶可以提高手术精度，减少併发症，并改善患者的整体康復。

哪些因素推动了止血剂和组织密封胶市场的成长？

止血剂和组织密封胶市场的成长受多种关键因素驱动，包括手术量增加、产品技术进步以及对微创手术需求的成长。其中一个关键驱动因素是全球老年人口的增长，老年人由于心血管疾病、关节重建和癌症等与老龄化相关的健康问题，往往需要接受更多手术。这些手术通常涉及更复杂、更精细的组织，需要精准的止血和有效的伤口缝合，从而增加了对先进止血剂和密封剂的需求。

技术创新，例如新一代生物活性止血剂和合成组织密封胶，也推动了市场成长。新型配方具有更高的疗效、更快的起效速度和更佳的生物相容性，使这些产品成为外科医生的必备工具。兼具止血和密封双重功效的组合产品的推出，简化了手术流程，加快了手术速度，并降低了併发症的发生率。此外，可生物降解树脂和合成树脂的选择，也拓展了这些产品在微创手术和机器人手术中的应用，在这些手术中，精准度和缩短恢復时间至关重要。

微创手术技术（包括腹腔镜手术和机器人辅助手术）的兴起也是推动止血材料和密封剂市场发展的关键因素。随着医疗机构和患者越来越倾向于选择恢復时间更短的微创手术，对能够在手术过程中有效控制出血和封闭组织的产品需求也日益增长。可透过小切口和腹腔镜器械使用的止血剂和密封剂，使外科医生能够在最大限度减少对周围组织损伤的情况下完成复杂的手术，从而改善患者预后并缩短住院时间。随着微创手术的日益普及，预计对这些专用产品的需求将进一步增长。

此外，心血管疾病、癌症和肥胖等慢性疾病的日益普遍，正推动着全球外科手术数量的成长。这些疾病通常需要进行复杂的组织处理手术，而这需要先进的止血和组织密封产品才能达到最佳治疗效果。随着此类慢性疾病的持续增加，尤其是在老龄化社会中，对可靠有效的止血和组织癒合手术工具的需求日益增长，从而推动了止血剂和密封剂的需求。

最后，监管机构的核准和医疗保健公司不断增加的投资正在推动市场扩张。随着更多创新止血剂和组织密封胶在美国、欧洲和亚太等主要市场获得监管部门的核准，外科医生和医疗保健人员能够更广泛地使用这些产品。外科医生对使用先进止血剂和密封剂益处的认识不断提高，以及製造商强有力的市场推广，也推动了这些产品的普及。随着医疗保健系统的不断发展和外科手术的日益复杂，预计对这些必需产品的需求将持续增长，止血剂和组织密封胶将成为现代外科手术护理的重要组成部分。

部分

产品类别（局部止血剂、黏合剂和组织密封胶），应用领域（外科修復、重组手术、一般外科手术、创伤病例、其他应用），最终用途（医院、专科诊所、门诊手术中心）

受访公司范例

• Advanced Medical Solutions Group PLC
• B. Braun Melsungen AG
• BARD, A Becton, Dickinson Company
• Baxter International, Inc.
• Cardinal Health, Inc.
• Cohera Medical, Inc.
• CryoLife, Inc.
• CSL Behring LLC
• Ethicon US, LLC
• HyperBranch Medical Technology, Inc.
• Integra Lifesciences Corporation
• Smith & Nephew PLC
• Teijin Pharma Ltd.
• Tissuemed Ltd.
• Vascular Solutions, Inc.
• Vivostat A/S
• Z-Medica, LLC

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具，革新市场和竞争情报。

全球行业分析师并没有遵循典型的LLM或特定行业的SLM查询，而是建立了一个内容库，其中收集了来自世界各地专家的信息，包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师预测，企业的竞争地位将根据其总部所在国家、製造地以及进出口（成品和OEM）情况而改变。这种复杂多变的市场动态预计将从多个方面影响竞争对手，包括销货成本成本上升、盈利下降以及供应链重组等，以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章 市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 澳洲
• 印度
• 韩国
• 亚太其他地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Hemostats and Tissue Sealants Market to Reach US$13.8 Billion by 2030

The global market for Hemostats and Tissue Sealants estimated at US$8.9 Billion in the year 2024, is expected to reach US$13.8 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Surgical Repairs Application, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$5.2 Billion by the end of the analysis period. Growth in the Reconstructive Surgeries Application segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 11.2% CAGR

The Hemostats and Tissue Sealants market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 11.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Hemostats and Tissue Sealants Market - Key Trends and Drivers Summarized

Are Hemostats and Tissue Sealants the Unsung Heroes in Surgical Success?

Hemostats and tissue sealants are essential tools in modern surgery, but why are they so critical in achieving successful outcomes? Hemostats are medical devices used to stop bleeding (hemostasis) during surgical procedures, while tissue sealants help close wounds and reinforce sutures, ensuring optimal healing. Together, they play a pivotal role in preventing excessive blood loss, reducing surgical time, and enhancing wound closure. Hemostasis is one of the most fundamental goals in any surgery, as uncontrolled bleeding can lead to severe complications, including infection, shock, and even death.

Hemostats work by either physically compressing blood vessels, activating the body’s natural clotting mechanisms, or using chemical agents to stop bleeding. Tissue sealants, on the other hand, act like glue, creating a barrier that promotes wound closure and healing. In various surgical fields, from cardiovascular and orthopedic to general and plastic surgery, these tools enable surgeons to control bleeding, reduce the need for transfusions, and ensure that wounds heal quickly and effectively. The development of advanced hemostats and sealants has revolutionized surgical care, offering surgeons more precise, reliable, and less invasive options to manage blood loss and tissue repair.

How Has Technology Transformed Hemostats and Tissue Sealants?

Technological advancements have dramatically improved the effectiveness, safety, and versatility of hemostats and tissue sealants, making them more integral to modern surgical practices. One of the key innovations is the development of biologically-derived and bioactive agents in these products. Traditionally, surgeons relied on mechanical compression or thermal cauterization to stop bleeding. Today, bioactive hemostats, which contain agents like collagen, thrombin, or fibrin, work by accelerating the body's natural clotting process. These bioactive agents are particularly useful in complex or minimally invasive surgeries, where traditional techniques may not be feasible or sufficient.

Tissue sealants have also evolved significantly, with new formulations that enhance their adhesive properties and biocompatibility. Synthetic sealants, such as cyanoacrylate-based glues, provide strong adhesion and are used to reinforce sutures or close incisions without the need for stitches. Biodegradable sealants, made from materials like polyethylene glycol (PEG), are designed to break down naturally in the body after serving their purpose, reducing the risk of foreign body reactions and infections. These advances have made tissue sealants safer and more effective for a wide range of applications, from delicate procedures like organ transplants to routine wound closure in cosmetic surgeries.

Another critical advancement is the development of combination products that integrate both hemostatic and tissue-sealing functions into a single solution. These multifunctional products can simultaneously stop bleeding and seal tissues, reducing the need for multiple interventions and streamlining the surgical process. Additionally, advancements in minimally invasive surgery have driven the need for hemostats and sealants that can be applied through laparoscopic or robotic instruments, allowing surgeons to control bleeding and seal tissues with precision in hard-to-reach areas. These technological improvements have not only enhanced the performance of hemostats and sealants but have also expanded their use across various medical fields, making surgeries safer and more efficient.

Why Are Hemostats and Tissue Sealants Critical for Surgical Outcomes?

Hemostats and tissue sealants are critical for ensuring successful surgical outcomes because they help manage one of the most dangerous aspects of surgery: uncontrolled bleeding. In many procedures, especially those involving delicate or vascular tissues, even small amounts of bleeding can lead to significant complications. Hemostats provide surgeons with immediate control over bleeding, reducing the need for more invasive measures and ensuring that the surgery can proceed smoothly. This control is especially vital in emergency surgeries or trauma care, where rapid blood loss must be managed immediately to prevent life-threatening conditions.

In addition to controlling bleeding, tissue sealants play a key role in wound management and postoperative recovery. By creating a watertight seal over surgical incisions or injured tissues, these sealants reduce the risk of infections and promote faster healing. They are particularly useful in surgeries where traditional sutures or staples may not be sufficient or appropriate, such as in liver resections, cardiovascular surgeries, or lung repairs. Tissue sealants also provide extra reinforcement in procedures involving large or high-tension wounds, helping to prevent wound dehiscence (the reopening of surgical incisions) and other complications during recovery.

Moreover, the use of hemostats and sealants reduces the need for blood transfusions, which can carry risks of infections, immune reactions, and longer hospital stays. By minimizing blood loss and improving wound closure, these products contribute to shorter surgical times, faster recovery periods, and better patient outcomes. For surgeons, having reliable hemostatic agents and sealants allows for greater precision, enabling them to focus on the complex aspects of the surgery without being hindered by excessive bleeding or concerns over tissue closure. Overall, the strategic use of hemostats and tissue sealants enhances surgical precision, reduces complications, and improves overall patient recovery.

What Factors Are Driving the Growth of the Hemostats and Tissue Sealants Market?

The growth of the hemostats and tissue sealants market is driven by several key factors, including the rising number of surgical procedures, advancements in product technology, and increasing demand for minimally invasive surgeries. One of the primary drivers is the growing global population of elderly individuals, who often require more surgeries due to age-related health issues such as cardiovascular diseases, joint replacements, and cancer. These surgeries, which tend to be more complex and involve delicate tissues, require precise control of bleeding and effective wound closure, driving demand for advanced hemostats and sealants.

Technological innovations, including the development of next-generation bioactive hemostats and synthetic tissue sealants, are also contributing to market growth. New formulations that offer improved efficacy, faster action, and better biocompatibility are making these products indispensable tools for surgeons. The introduction of combination products that serve both as hemostats and sealants has streamlined surgical workflows, making procedures faster and reducing the likelihood of complications. Additionally, the increasing availability of biodegradable and synthetic options has expanded the use of these products in minimally invasive and robotic surgeries, where precision and reduced recovery times are paramount.

The rise of minimally invasive surgical techniques, including laparoscopic and robotic-assisted surgeries, is another significant factor driving the market for hemostats and sealants. As healthcare providers and patients alike seek less invasive procedures with shorter recovery times, the need for products that can effectively control bleeding and close tissues in these types of surgeries has grown. Hemostats and sealants that can be applied via small incisions or through laparoscopic instruments allow surgeons to perform complex procedures with minimal damage to surrounding tissues, improving patient outcomes and reducing hospital stays. As minimally invasive surgeries become more common, demand for these specialized products is expected to increase further.

Furthermore, the increasing prevalence of chronic diseases such as cardiovascular disorders, cancer, and obesity is leading to a higher number of surgical interventions globally. These conditions often require surgeries that involve complex tissue management, where advanced hemostatic and tissue-sealing products are necessary to ensure optimal outcomes. As these chronic diseases continue to rise, particularly in aging populations, the need for reliable and effective surgical tools to manage blood loss and tissue healing will grow, driving the demand for hemostats and sealants.

Lastly, regulatory approvals and growing investments by healthcare companies are contributing to market expansion. As more innovative hemostatic agents and tissue sealants gain regulatory approval in key markets such as the U.S., Europe, and Asia-Pacific, they are becoming more widely available to surgeons and healthcare providers. Increased awareness among surgeons about the benefits of using advanced hemostats and sealants, coupled with strong marketing efforts by manufacturers, is also fueling adoption. As healthcare systems continue to evolve and surgical procedures become more sophisticated, the demand for these critical products is expected to grow, positioning hemostats and tissue sealants as essential components of modern surgical care.

SCOPE OF STUDY:

The report analyzes the Hemostats and Tissue Sealants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Segment (Topical Hemostats, Adhesive & Tissue Sealants); Application (Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases, Other Applications); End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

• Advanced Medical Solutions Group PLC
• B. Braun Melsungen AG
• BARD, A Becton, Dickinson Company
• Baxter International, Inc.
• Cardinal Health, Inc.
• Cohera Medical, Inc.
• CryoLife, Inc.
• CSL Behring LLC
• Ethicon US, LLC
• HyperBranch Medical Technology, Inc.
• Integra Lifesciences Corporation
• Smith & Nephew PLC
• Teijin Pharma Ltd.
• Tissuemed Ltd.
• Vascular Solutions, Inc.
• Vivostat A/S
• Z-Medica, LLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • Global Economic Update
  • Hemostats and Tissue Sealants - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Expansion of Surgical Procedures in Cardiovascular and Orthopedic Applications Propels Market Adoption
  • Technological Advancements in Absorbable Hemostats and Sealants Propel Innovation
  • Role of Hemostats and Tissue Sealants in Reducing Post-operative Complications Strengthens Business Case
  • Increasing Focus on Biocompatible and Natural Hemostatic Agents Bodes Well for Market Growth
  • Expansion of Outpatient and Ambulatory Surgical Centers Fuels Demand for Hemostats and Sealants
  • Growth in Use of Tissue Sealants in Plastic and Reconstructive Surgeries Expands Market Potential
  • Expansion of Hemostats and Sealants in Dental and ENT Surgeries Strengthens Market Opportunities
  • Increasing Adoption of Synthetic and Fibrin-based Sealants in Surgical Practices Expands Market
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Surgical Repairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Surgical Repairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Surgical Repairs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Reconstructive Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Reconstructive Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Reconstructive Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for General Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for General Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for General Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Trauma Cases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Trauma Cases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Trauma Cases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Topical Hemostats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Topical Hemostats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Topical Hemostats by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Adhesive & Tissue Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Adhesive & Tissue Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Adhesive & Tissue Sealants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 30: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 31: World Hemostats and Tissue Sealants Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hemostats and Tissue Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Hemostats and Tissue Sealants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Hemostats and Tissue Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• JAPAN
  • Hemostats and Tissue Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• CHINA
  • Hemostats and Tissue Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• EUROPE
  • Hemostats and Tissue Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Hemostats and Tissue Sealants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Hemostats and Tissue Sealants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
• FRANCE
  • Hemostats and Tissue Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• GERMANY
  • Hemostats and Tissue Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Hemostats and Tissue Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Hemostats and Tissue Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Hemostats and Tissue Sealants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Hemostats and Tissue Sealants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
• AUSTRALIA
  • Hemostats and Tissue Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• INDIA
  • Hemostats and Tissue Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Hemostats and Tissue Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Hemostats and Tissue Sealants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Hemostats and Tissue Sealants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Hemostats and Tissue Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Hemostats and Tissue Sealants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Hemostats and Tissue Sealants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• AFRICA
  • Hemostats and Tissue Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Hemostats and Tissue Sealants by Application - Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Hemostats and Tissue Sealants by Application - Percentage Breakdown of Value Sales for Surgical Repairs, Reconstructive Surgeries, General Surgeries, Trauma Cases and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Hemostats and Tissue Sealants by Segment - Topical Hemostats and Adhesive & Tissue Sealants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Hemostats and Tissue Sealants by Segment - Percentage Breakdown of Value Sales for Topical Hemostats and Adhesive & Tissue Sealants for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Hemostats and Tissue Sealants by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Hemostats and Tissue Sealants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION